It has been speculated that CD155 expression leads to tumor immunosuppression [9], because the interaction of CD155 with TIGIT or CD96-positive T lymphocytes and NK cells results in exhaustion of immune function, in addition to reducing the secretion of interferon-γ [29,30]. This evidence concerns the gene PVR and neoplasm.